Arca
Skip to content
Tools
Tools

-cog

A blood clotting factor, used in haemophilia.

  • Drugs ending in -cog: 22
  • Approved somewhere: 17
  • With a US drug page: 0

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-cog
Class
Blood clotting factors, used in bleeding disorders
Most common targets
F8 (11), F9 (4), F7 (3), F13A1 (1), VWF (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -cog or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
CatridecacogApprovedF13A1Coagulation factor XIII exogenous protein
Eptacog alfa (activated)ApprovedF7Coagulation factor VII exogenous protein
Eptacog beta (activated)ApprovedF7Coagulation factor VII exogenous protein
Nonacog beta pegolApprovedF9Coagulation factor IX exogenous protein
Octocog alfaApprovedF8Coagulation factor VIII exogenous protein
Vonicog alfaApprovedVWFvon Willebrand factor exogenous protein
Eptacog alfa pegol (activated)Phase 1F7Coagulation factor VII exogenous protein
Vatreptacog alfa (activated)Phase 2——
Marzeptacog alfa (activated)Phase 1——
Albutrepenonacog alfaApprovedF9Coagulation factor IX exogenous protein
Eftrenonacog alfaApprovedF9Coagulation factor IX exogenous protein
Trenonacog alfaPhase 3F9Coagulation factor IX exogenous protein
Damoctocog alfa pegolApprovedF8Coagulation factor VIII exogenous protein
Efanesoctocog alfaApprovedF8Coagulation factor VIII exogenous protein
Efmoroctocog alfaApprovedF8Coagulation factor VIII exogenous protein
Lonoctocog alfaApprovedF8Coagulation factor VIII exogenous protein
Moroctocog alfaApprovedF8Coagulation factor VIII exogenous protein
Simoctocog alfaApprovedF8Coagulation factor VIII exogenous protein
Susoctocog alfaApprovedF8Coagulation factor VIII exogenous protein
Turoctocog alfaApprovedF8Coagulation factor VIII exogenous protein
Turoctocog alfa pegolApprovedF8Coagulation factor VIII exogenous protein
Omfiloctocog alfaPhase 3F8Coagulation factor VIII exogenous protein

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.